blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2148934

EP2148934 - MATRIX MARKER MODEL AND METHODS FOR ASSESSING AND TREATING RHEUMATOID ARTHRITIS [Right-click to bookmark this link]
Former [2010/05]MATRIX MARKER MODEL AND METHODS FOR ASSESSING AND TREATING ARTHRITIS AND RELATED DISORDERS
[2011/33]
StatusNo opposition filed within time limit
Status updated on  25.01.2013
Database last updated on 31.08.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Janssen Biotech, Inc.
800/850 Ridgeview Drive
Horsham, PA 19044 / US
[2011/44]
Former [2010/05]For all designated states
Centocor Ortho Biotech, Inc.
200 Great Valley Parkway
Malvern, Pennsylvania 19355 / US
Inventor(s)01 / HAN, Chenglong
200 Great Valley Parkway
Malvern, Pennsylvania 19355 / US
02 / NOEL, Wim
Kleine Hagenstraat 42
1980 Zemst / BE
03 / VASTESAEGER, Nathan
Tiensesteenweg 107
3010 Kessel Lo / BE
 [2010/05]
Representative(s)Marshall, Cameron John, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2012/12]Marshall, Cameron John, et al
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Former [2010/05]Marshall, Cameron John, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date08769291.905.05.2008
[2010/05]
WO2008US62621
Priority number, dateUS20070915724P03.05.2007         Original published format: US 915724 P
[2010/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008137828
Date:13.11.2008
Language:EN
[2008/46]
Type: A1 Application with search report 
No.:EP2148934
Date:03.02.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 13.11.2008 takes the place of the publication of the European patent application.
[2010/05]
Type: B1 Patent specification 
No.:EP2148934
Date:21.03.2012
Language:EN
[2012/12]
Search report(s)International search report - published on:US13.11.2008
(Supplementary) European search report - dispatched on:EP07.06.2010
ClassificationIPC:C12Q3/00, G01N33/68
[2010/26]
CPC:
G01N33/6887 (EP,US); A61P19/02 (EP); A61P29/00 (EP);
G01N2800/102 (EP,US); G01N2800/52 (EP,US)
Former IPC [2010/05]C12Q3/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/05]
TitleGerman:MATRIX-MARKER-MODELL UND VERFAHREN ZUR ÜBERPRÜFUNG UND BEHANDLUNG VON RHEUMATISCHER ARTHRITIS[2011/33]
English:MATRIX MARKER MODEL AND METHODS FOR ASSESSING AND TREATING RHEUMATOID ARTHRITIS[2011/33]
French:MODÈLE DE MARQUEUR DE MATRICE ET PROCÉDÉS POUR ÉVALUER ET TRAITER L'ARTHRITE RHUMATOIDE[2011/33]
Former [2010/05]MATRIX-MARKER-MODELL UND VERFAHREN ZUR ÜBERPRÜFUNG UND BEHANDLUNG VON ARTHRITIS UND DAMIT ZUSAMMENHÄNGENDEN ERKRANKUNGEN
Former [2010/05]MATRIX MARKER MODEL AND METHODS FOR ASSESSING AND TREATING ARTHRITIS AND RELATED DISORDERS
Former [2010/05]MODÈLE DE MARQUEUR DE MATRICE ET PROCÉDÉS POUR ÉVALUER ET TRAITER L'ARTHRITE ET DES TROUBLES ASSOCIÉS
Entry into regional phase23.11.2009National basic fee paid 
23.11.2009Search fee paid 
23.11.2009Designation fee(s) paid 
23.11.2009Examination fee paid 
Examination procedure23.11.2009Examination requested  [2010/05]
21.12.2010Amendment by applicant (claims and/or description)
24.01.2011Despatch of a communication from the examining division (Time limit: M04)
03.06.2011Reply to a communication from the examining division
21.09.2011Communication of intention to grant the patent
01.02.2012Fee for grant paid
01.02.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.01.2011
Opposition(s)02.01.2013No opposition filed within time limit [2013/09]
Fees paidRenewal fee
31.03.2010Renewal fee patent year 03
11.05.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.05.2008
AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
IT21.03.2012
LT21.03.2012
LV21.03.2012
MT21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
TR21.03.2012
IE05.05.2012
LU05.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
BG21.06.2012
NO21.06.2012
GR22.06.2012
ES02.07.2012
IS21.07.2012
PT23.07.2012
[2014/34]
Former [2014/27]AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
IT21.03.2012
LT21.03.2012
LV21.03.2012
MT21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
TR21.03.2012
IE05.05.2012
LU05.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
BG21.06.2012
NO21.06.2012
GR22.06.2012
ES02.07.2012
IS21.07.2012
PT23.07.2012
Former [2014/21]AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
IT21.03.2012
LT21.03.2012
LV21.03.2012
MT21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
TR21.03.2012
IE05.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
BG21.06.2012
NO21.06.2012
GR22.06.2012
ES02.07.2012
IS21.07.2012
PT23.07.2012
Former [2013/35]AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
IT21.03.2012
LT21.03.2012
LV21.03.2012
MT21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
IE05.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
BG21.06.2012
NO21.06.2012
GR22.06.2012
ES02.07.2012
IS21.07.2012
PT23.07.2012
Former [2013/33]AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
IT21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
IE05.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
BG21.06.2012
NO21.06.2012
GR22.06.2012
ES02.07.2012
IS21.07.2012
PT23.07.2012
Former [2013/22]AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
IT21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
IE05.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
NO21.06.2012
GR22.06.2012
ES02.07.2012
IS21.07.2012
PT23.07.2012
Former [2013/20]AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
IT21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
IE05.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
NO21.06.2012
GR22.06.2012
IS21.07.2012
PT23.07.2012
Former [2013/11]AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
IT21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
NO21.06.2012
GR22.06.2012
IS21.07.2012
PT23.07.2012
Former [2013/08]AT21.03.2012
CY21.03.2012
CZ21.03.2012
DK21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
NO21.06.2012
GR22.06.2012
IS21.07.2012
PT23.07.2012
Former [2013/07]AT21.03.2012
CY21.03.2012
CZ21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
NO21.06.2012
GR22.06.2012
IS21.07.2012
PT23.07.2012
Former [2013/03]CY21.03.2012
CZ21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
MC31.05.2012
NO21.06.2012
GR22.06.2012
IS21.07.2012
PT23.07.2012
Former [2013/01]CY21.03.2012
CZ21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
NO21.06.2012
GR22.06.2012
IS21.07.2012
PT23.07.2012
Former [2012/50]CY21.03.2012
CZ21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
SK21.03.2012
NO21.06.2012
GR22.06.2012
IS21.07.2012
Former [2012/49]CY21.03.2012
CZ21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
PL21.03.2012
RO21.03.2012
SE21.03.2012
SI21.03.2012
NO21.06.2012
GR22.06.2012
IS21.07.2012
Former [2012/48]CY21.03.2012
EE21.03.2012
FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
SE21.03.2012
NO21.06.2012
GR22.06.2012
Former [2012/41]CY21.03.2012
FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
NO21.06.2012
GR22.06.2012
Former [2012/39]FI21.03.2012
HR21.03.2012
LT21.03.2012
LV21.03.2012
NO21.06.2012
GR22.06.2012
Former [2012/37]FI21.03.2012
HR21.03.2012
LT21.03.2012
NO21.06.2012
GR22.06.2012
Former [2012/36]HR21.03.2012
LT21.03.2012
NO21.06.2012
GR22.06.2012
Former [2012/34]LT21.03.2012
NO21.06.2012
Documents cited:Search[X]  - SALEEM ET AL, "Biomarkers: Strategies to predict outcome of rheumatoid arthritis", DRUG DISCOVERY TODAY: THERAPEUTIC STRATEGIES, ELSEVIER LNKD- DOI:10.1016/J.DDSTR.2006.02.004, (20060401), vol. 3, no. 1, ISSN 1740-6773, pages 11 - 16, XP005394583 [X] 1-10 * the entire document, particularly abstract, page 14 and table I *

DOI:   http://dx.doi.org/10.1016/j.ddstr.2006.02.004
 [Y]  - VAN DER HELM - VAN MIL AHM ET AL, "A Prediction Rule for Disease Outcome in Patients With Recent-Onset Undifferentiated Arthritis", ARTHRITIS & RHEUMATISM, (20070201), vol. 56, no. 2, pages 433 - 440, XP002582914 [Y] 1-10 * abstract * * page 434 *

DOI:   http://dx.doi.org/10.1002/art.22380
 [Y]  - JANSEN LMA ET AL, "Predictors of radiographic joint damage in patients with early rheumatoid arthritis", ANNALS OF THE RHEUMATIC DISEASES, (20011001), vol. 60, pages 924 - 927, XP002582915 [Y] 1-10 * abstract * * page 926 *
 [Y]  - VISSER H, "Early diagnosis of rheumatoid arthritis", BAILLIERE'S BEST PRACTICE AND RESEARCH. CLINICAL REUMATOLOGY, BAILLIERE TINDALL, LONDON, GB LNKD- DOI:10.1016/J.BERH.2004.08.005, (20050201), vol. 19, no. 1, ISSN 1521-6942, pages 55 - 72, XP004672995 [Y] 1-10 * abstract * * page 67 - page 68 *

DOI:   http://dx.doi.org/10.1016/j.berh.2004.08.005
 [Y]  - VISSER HENK ET AL, "How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis", ARTHRITIS & RHEUMATISM, JOHN WILEY & SONS, INC, US, (20020201), vol. 46, no. 2, ISSN 0004-3591, pages 357 - 365, XP002388616 [Y] 1-10 * abstract *
International search[X]US2006141547  (DAS HASI R [IN], et al);
 [Y]US7184814  (LANG PHILIPP [US], et al);
 [Y]  - KEYSTONE ET AL, "Radiographic, Clinical, and Functional Outcomes of Treatment With Adalimumab (a Human Anti-Tumor Necrosis Factor Monoclonal Antibody) in Patients With Active Rheumatoid Arthritis Receiving Concomitant Methotrexate Therapy", ARTHRITIS & RHEUMATISM, (2004), vol. 50, pages 1400 - 1411, XP008125662

DOI:   http://dx.doi.org/10.1002/ART.20217
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.